E173 - The Leading Edge of Colon Cancer Treatments, with Jenny Seligmann
Cold Steel: Canadian Journal of Surgery PodcastShow Notes
This week we were joined by Dr. Jenny Seligmann. Dr. Seligmann is a Professor of Gastrointestinal and Translational Oncology and Honorary Consultant in Medical Oncology at the University of Leeds. Dr. Seligmann is one of the authors of the seminal FOxTROT trial, which investigated the use of neoadjuvant chemotherapy in advanced colon cancers. Dr. Seligmann is the lead investigator on the FOxTROT platform, the ARIEL trial, and continues to be on the leading edge of trials for colorectal cancer. In this episode, we explored neoadjuvant chemotherapy for colon cancer specifically. There's lots to take away from this conversation, but one of the things that stood out for us was some of the differences in the structure of the multidisciplinary tumor boards in Dr. Seligmann’s centre versus many centres in Canada. Perhaps in the future, all colorectal cancers will get discussed at tumor boards! What do you think? We’d love to hear your thoughts – email us at [email protected]. Bio: Dr Jenny Seligmann is Professor of Gastrointestinal and Translational Oncology and Honorary Consultant in Medical Oncology at the University of Leeds, UK. She is the Chief Investigator of the FOxTROT Platform and the ARIEL trial, and has a programme of translational research. She is a member of the ESMO Lower Gastrointestinal Faculty and the UK NCRI Colorectal Cancer Executive Group. x/twitter: @jenseligmann Links: Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial. https://ascopubs.org/doi/10.1200/JCO.22.00046 Professor Dion Morton: https://www.birmingham.ac.uk/staff/profiles/applied-health/morton-dion Professor Phil Quirke: https://medicinehealth.leeds.ac.uk/medicine/staff/700/professor-philip-quirke ARIEL trial: https://fundingawards.nihr.ac.uk/award/NIHR129268 FOCUS4 trial: http://www.focus4trial.org/ FOxTROT platform website: https://ctru.leeds.ac.uk/foxtrot/ COLOSOS trial: https://mycs-cdn.myconferencesuite.com/other/Project/3222/91/c0/PRELIM%20PROGRAM_COLOSOS%20CANADA_DL.pdf
More from Cold Steel: Canadian Journal of Surgery Podcast
How can we better prepare ourselves and our trainees for sitting the oral exam? By this point, residents have typically already passed their written exam. And so they have the book knowledge, but how do you get that book knowledge from inside your brain to your mouth and obvious obviously, onto your examiner and onto their page? To answer that question, I invited Dr. Sorena Afshar onto the podcast this week.
Why is a surgical podcast talking about tax credits????
AI is likely to change the way that medical and surgical education happens over the next decade. We needed to find out how, and Dr. Samir Grover joined us on this episode to talk about it.
Jeremy Heffner is a trauma and acute care surgeon at Lima Memorial Health System in Ohio. He is also the Chief Operating Officer of SurgeON, a social media company dedicated to surgeons. Heffner was also previously a bioengineer who worked at NIH. He has been incredibly open about his journey and struggles with PTSD as a surgeon, and how those struggles ultimately caused his breakdown. Sadly, Dr. Heffner's story is not unique, and we brought him on the podcast to hear his insights about how many surgeons struggle with PTSD.